Key Takeaway
What to expect on semaglutide 2.4mg, the full maintenance dose. Learn about appetite changes, weight loss trajectory, side effects, and how to get the best results at this dose.
Semaglutide 2.4mg is the full maintenance dose used in the Wegovy clinical program. At this level, you can expect the strongest appetite suppression, the most significant weight loss results, and the full range of metabolic benefits that semaglutide delivers. Most patients reach this dose at week 17 of the standard titration schedule.
Why 2.4mg Is the Target Maintenance Dose
Semaglutide 2.4mg was selected as the maintenance dose for the Wegovy weight management program based on dose-finding studies that evaluated efficacy across multiple dose levels. The Phase 2 dose-ranging trial tested doses from 0.05mg to 0.4mg daily (equivalent to approximately 0.35mg to 2.8mg weekly). The 2.4mg weekly dose delivered the optimal balance of weight loss efficacy with an acceptable side effect profile.
By the time you reach 2.4mg, you have spent approximately 16 weeks titrating through four lower dose steps. This gradual approach has allowed your GI tract to adapt to the medication and your appetite set point to shift progressively. The transition from 1.7mg to 2.4mg represents a 41% dose increase, so some patients do notice a new wave of effects during the first 2 to 4 weeks at this dose.
What You Will Likely Experience
Appetite and Hunger
At 2.4mg, appetite suppression reaches its peak. Most patients describe a fundamental shift in their relationship with food. The constant background noise of food thoughts, cravings, and urges that many people with obesity experience tends to quiet dramatically. You may find that you forget to eat or feel full after just a few bites. For a complete cost breakdown, see our affordable GLP-1 options.
View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
This effect is driven by semaglutide's action on GLP-1 receptors in the hypothalamus, the brain region that regulates hunger and satiety. At the full maintenance dose, receptor occupancy is at its highest, producing the most strong appetite control.
Weight Loss Trajectory
In STEP 1[1], patients who reached and stayed at 2.4mg lost an average of 14.9% of their body weight over 68 weeks. Over one-third of participants lost 20% or more.
Weight loss at 2.4mg follows a characteristic pattern:
- Weeks 17 to 28: Rapid weight loss continues as the full dose takes effect. Many patients lose 1 to 2 pounds per week during this phase.
- Weeks 28 to 44: Weight loss gradually decelerates but continues. Average loss is about 0.5 to 1 pound per week.
- Weeks 44 to 68: Most patients approach a new weight plateau. Weight loss slows to near zero as the body reaches a new equilibrium between energy intake and expenditure.
Gastrointestinal Adjustments
The jump to 2.4mg brings a temporary increase in GI side effects for many patients. In STEP 1, the most common side effects at the 2.4mg dose included :
- Nausea: 44% (vs. 17% placebo)
- Diarrhea: 30% (vs. 16% placebo)
- Vomiting: 25% (vs. 7% placebo)
- Constipation: 24% (vs. 11% placebo)
These rates reflect the entire treatment period and include effects during dose escalation. Most GI symptoms are mild to moderate and improve within 4 to 6 weeks of reaching 2.4mg. Fewer than 7% of patients discontinued due to GI side effects.
Energy and Mood
Many patients report improved energy levels at 2.4mg as weight decreases and metabolic health improves. Sleep quality often gets better, especially in patients with sleep apnea, as excess weight around the airway decreases. Some patients also report mood improvements, though this may be related to the confidence and mobility gains from weight loss rather than a direct drug effect.
Metabolic Improvements
At the full maintenance dose, semaglutide produces broad metabolic benefits:
- Blood pressure reduction: average 4 to 5 mmHg systolic
- Triglyceride reduction: average 12 to 18%
- HbA1c improvement: 0.5 to 1.5 percentage points in patients with prediabetes or type 2 diabetes
- CRP reduction: approximately 37% (from SELECT trial[2] data)
- Waist circumference reduction: average 5 to 6 inches over the full treatment period
Managing the Transition to 2.4mg
- Eat smaller meals more frequently. Your stomach empties more slowly at this dose. Large meals increase nausea risk.
- Focus on protein first. Aim for at least 25 to 30 grams of protein per meal to preserve lean muscle mass during rapid weight loss.
- Hydrate aggressively. Drink 64 to 80 ounces of water daily. Dehydration worsens nausea and constipation.
- Avoid fatty and fried foods. Delayed gastric emptying makes rich foods more likely to trigger nausea.
- Take a daily multivitamin. Reduced food intake means reduced micronutrient intake. A basic multivitamin plus additional vitamin D and calcium helps fill gaps.
- Incorporate resistance exercise. At 2.4mg, weight loss is rapid enough that muscle loss becomes a real concern. Strength training 2 to 3 times per week is strongly recommended. exercise recommendations on semaglutide
Medical References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. [PubMed | ClinicalTrials.gov | DOI]
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. [PubMed | ClinicalTrials.gov | DOI]
Frequently Asked Questions
- How long will I stay on semaglutide 2.4mg?
- Semaglutide 2.4mg is designed as a long-term maintenance medication. The STEP 1 extension study showed that patients who stopped semaglutide regained approximately two-thirds of lost weight within a year. Most prescribers recommend continuing the medication indefinitely to maintain results.
- Is 2.4mg the highest dose of semaglutide?
- For the Wegovy weight management indication, yes. Ozempic for type 2 diabetes goes up to 2mg. Higher investigational doses (up to 7.2mg weekly) have been studied but aren't currently available.
- What if I can't tolerate 2.4mg?
- You can step back to 1.7mg. Many patients achieve good long-term results at 1.7mg when the full 2.4mg dose causes unacceptable side effects. Your prescriber can guide this decision. semaglutide 1.7mg how long to stay on
- Will I keep losing weight at 2.4mg or will I plateau?
- Most patients reach a weight plateau after 9 to 12 months on the maintenance dose. This plateau represents a new energy balance, not medication failure. Continued use of semaglutide is necessary to maintain the weight loss achieved.
- Can I drink alcohol at the 2.4mg dose?
- Moderate alcohol consumption isn't contraindicated, but many patients report lower alcohol tolerance while on semaglutide. Alcohol can also worsen nausea and adds empty calories that may slow progress. Limiting intake is advisable.